LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026)
LivaNova's (LIVN) quarterly Other Non-Current Liabilities came in at $54.4 million in Q1 2026, down 36.13% year-on-year from $85.1 million in Q1 2025, and up 29.34% quarter-over-quarter from $42.0 million in Q4 2025.
LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026) Analysis & Trends
LivaNova has disclosed Other Non-Current Liabilities across 12 years of filings, most recently posting $54.4 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $54.4 million, down 36.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.4 million (down 36.13% YoY), and the FY2025 annual result was $42.0 million, down 5.47% from the prior year.
- Other Non-Current Liabilities came in at $54.4 million for Q1 2026 at LivaNova, up from $42.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $134.1 million in Q2 2022 to a low of $42.0 million in Q4 2025.
- The 5-year median for Other Non-Current Liabilities is $80.9 million (2023), against an average of $75.1 million.
- Across the five-year window, Other Non-Current Liabilities jumped 74.56% in 2024 and sank 50.01% in 2025, its largest moves.
- LivaNova's Other Non-Current Liabilities stood at $91.6 million in 2022, then fell by 11.64% to $80.9 million in 2023, then sank by 45.02% to $44.5 million in 2024, then declined by 5.47% to $42.0 million in 2025, then gained by 29.34% to $54.4 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $54.4 million (Q1 2026), $42.0 million (Q4 2025), and $64.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.38 Mn |
| Dec 31, 2025 | 42.05 Mn |
| Sep 30, 2025 | 64.52 Mn |
| Jun 30, 2025 | 52.70 Mn |
| Mar 31, 2025 | 85.14 Mn |
| Dec 31, 2024 | 44.48 Mn |
| Sep 30, 2024 | 84.16 Mn |
| Jun 30, 2024 | 105.41 Mn |
| Mar 31, 2024 | 80.77 Mn |
| Dec 31, 2023 | 80.90 Mn |
| Sep 30, 2023 | 53.30 Mn |
| Jun 30, 2023 | 92.63 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Dec 31, 2022 | 91.56 Mn |
| Sep 30, 2022 | 81.85 Mn |
| Jun 30, 2022 | 134.09 Mn |
| Mar 31, 2022 | 83.34 Mn |
| Dec 31, 2021 | 86.83 Mn |
| Jun 30, 2021 | 97.05 Mn |
| Mar 31, 2021 | 148.28 Mn |